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Edited by Maurice MontalAbstract We have puriﬁed BoiTx1, the ﬁrst toxin from the ve-
nom of the Israeli scorpion, Buthus occitanus israelis, and stud-
ied its activity and genomic organization. BoiTx1 is a 37 amino
acid-long peptide contained six conserved cysteines, and is clas-
siﬁed as an a-KTx3.10 toxin. The pharmacological eﬀects of
BoiTx1 were studied on various cloned K+ channels expressed
in Xenopus laevis oocytes. BoiTx1 inhibited currents through
Drosophila Shaker channels with an IC50 value of
3.5 ± 0.5 nM, yet had much lesser eﬀect on its mammalian
orthologs. Thus, BoiTx1 is the ﬁrst member of the a-KTx3 fam-
ily that preferentially aﬀects insect potassium channels.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Since the isolation of noxiustoxin, the ﬁrst short chain potas-
sium channel-blocking toxin from the venom of Centruroides
noxius [1,2], scorpion venoms have been considered as rich
sources of potassium channel-blocking peptides [3–5]. Potas-
sium channel-blocking toxins are typically 23–64 amino acid
residues in length and well-packed by either three or four disul-
ﬁde bridges. Toxin peptides are structurally related, with a
structural signature deﬁned by the presence of the cysteine-sta-
bilized a/b motif, in which two disulﬁde bridges covalently link
a a-helical segment with one strand of a b-sheet structure [3–5].
To date, more than 120 potassium channel modiﬁers have been
discovered and are divided into four major families (a-, b-, c-
and j-KTx’s), grouped according to their primary sequence
[5]. a-KTx’s can, in turn, be divided into more than 20 inde-
pendent sub-families [5–7].
Characteristic of scorpion toxins is their ability to distin-
guish between diﬀerent channel sub-types and even between
orthologous channels [8]. Moreover, several sodium channel
modiﬁers were shown to possess impressive selectivity towardsAbbreviations: MALDI-TOF, matrix-assisted laser desorption ioniza-
tion–time-of-ﬂight; HPLC, high performance liquid chromatography;
KTx, K+ channel toxin; Kv, voltage-gated K+ channel; TFA,
triﬂuoroacetic acid; DTT, dithiothreitol; TEVC, two-electrode voltage
clamp technique; BSA, bovine serum albumin
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selective sodium channel modiﬁers [9–11].
There are nine known members of the a-KTx3 toxin group,
agents that block certain Shaker and Shaker-like Kv1.x volt-
age-gated potassium channels as well as some calcium-acti-
vated potassium channels [12–15]. Here, we describe the
isolation and cloning of the ﬁrst toxin from the Israeli scor-
pion, Buthus occitanus israelis [16]. The toxin, termed BoiTx1,
is a new member of the a-KTx3 toxin family and is at least a
hundredfold more potent against the ﬂy Shaker channel than
towards its mammalian homologs, Kv1.1 and Kv1.3.2. Materials and methods
2.1. Toxin puriﬁcation
B. occitanus israelis scorpions were collected in the Negev desert of
Israel and crude venom was extracted by electrical stimulation of the
venom gland [17]. Crude venom from 40 scorpions was lyophilized,
suspended in 200 ll of 10 mM ammonium acetate and centrifuged
at 13,000 · g for 15 min at 4 C. The pellet was extracted two more
times and the combined supernatants were ﬁltered through a
0.2 lm ﬁlter.
High performance liquid chromatography (HPLC) analyses were
performed on an AKTAbasic puriﬁer (Amersham Biosciences). Crude
venom was separated on a 3 ml Resource RPC column (Amersham
Biosciences) using buﬀer A (0.1% triﬂuoroacetic acid (TFA) in water)
and buﬀer B (0.1% TFA in acetonitrile) in the following gradient: 0–8%
buﬀer B (6 min), 8–45% buﬀer B (36 min) and ﬁnally, 45–100% buﬀer B
(6 min). Fractions were lyophilized and dissolved in 20 mM ammo-
nium acetate (buﬀer A). Active fractions were applied to a 1 ml Re-
source S cation exchange column (Amersham Biosciences), using
1 M NaCl in 20 mM ammonium acetate as buﬀer B. Separation was
performed using buﬀers A and B in a linear gradient of 0–60% buﬀer
B (18 min) followed by a linear gradient of 60–100% buﬀer B (2 min).
Final puriﬁcation of the active fractions were performed using a Vydac
C18 (4.6 · 250 mm) column using buﬀer A (0.1% TFA in water) and
buﬀer B (0.1% TFA in acetonitrile) in the following gradient: 5–10%
buﬀer B (2 min), 10–40% buﬀer B (62 min) and ﬁnally, 40–100% buﬀer
B (8 min).2.2. Mass spectrometry analysis and amino acid sequencing
The molecular weights of the puriﬁed and chymotrypsin-digested
toxin were determined using matrix-assisted laser desorption ioniza-
tion-time-of-ﬂight (MALDI-TOF) spectroscopy (Reﬂex IV, Bruker
Daltonics), performed at the Biotechnology Institute of Ben-Gurion
University. Toxin preparation for digestion included successive dena-
turation, reduction and alkalization using 8 M urea, 450 mM dithio-
threitol (DTT) and 500 mM iodoacetamide at room temperature for
20 min. Chymotryptic digestion of the treated toxin was carried out
in digestion buﬀer containing 10 mM CaCl2, 100 mM Tris–HCl pH
7.8 at 30 C over night.
The ﬁrst ﬁve amino acid sequence of the toxin was determined via
Edman degradation, carried out by the Protein Microsequencing Facil-
ity of the Weizmann Institute (Rehovot, Israel).blished by Elsevier B.V. All rights reserved.
A. Kozminsky-Atias et al. / FEBS Letters 581 (2007) 2478–2484 24792.3. Electrophysiology activity assay
Xenopus laevis oocytes were isolated, defolliculated and maintained
at 17 C in ND-91 solution (in mM): 91 NaCl, 2 KCl, 1.8 CaCl2, 1
MgCl2, and 5 HEPES, pH 7.5, supplemented with 100 U/ml penicillin,
100 lg/ml streptomycin and 50 lg/ml gentamycin. Oocytes were in-
jected with 23 or 46 nl, containing 0.2–15 ng of cRNA. Whole-cell cur-
rents were measured 1–3 days after injection by the two-electrode
voltage clamp technique (TEVC), using a GeneClamp 500B ampliﬁer
(Axon Instruments). Data were ﬁltered at 0.5 kHz and sampled at
2 kHz with Clampex 9.0 software (Axon Instruments). The pipette
was ﬁlled with 3 M KCl and the bath solution contained (in mM): 4
KCl, 96 NaCl, 1 MgCl2, 0.3 CaCl2, 5 HEPES, pH 7.4. For activity
measurements, the toxin was suspended in 20 mM ammonium acetate
supplemented with 100 lg/ml bovine serum albumin (BSA), diluted in
the external solution supplemented with 100 lg/ml BSA and added di-
rectly to the chamber.
2.4. cDNA library construction and screening
Total RNA was extracted 3 days after electrical ‘milking’ of the ve-
nom glands, using the EZ RNA extraction kit (Promega), while
mRNA was puriﬁed using the PolyATract mRNA Isolation System
(Promega). Double-stranded cDNA was synthesized from 2 lg of
mRNA with the Universal Riboclone cDNA Synthesis System (Pro-
mega). cDNA was cloned into pBluescript KS+ plasmids digested with
SmaI and transfected into Escherichia coli DH5a cells. Three hundred
randomly chosen cDNAs, ranging in length from 250 to 600 bp, were
sequenced to obtain a reliable representation of the toxin content in the
venom gland.
2.5. DNA preparation and ampliﬁcation
Genomic DNA was puriﬁed from abdomen segments of three scor-
pions using an EZ DNA kit (Bet Haemek, Israel). Primers used for
PCR ampliﬁcation were designed to match the 5 0- and 3 0-untranslated
regions of the cDNA. The forward primer was 5 0-GGGTTTATTTG-0
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Fig. 1. Puriﬁcation of BoiTx1 from the venom of Buthus occitanus israelis. V
three successive steps, using (A) a 3 ml RPC column (Amersham Bioscie
Biosciences) and (C) a Vydac C18 (4.6 · 250 mm) column. BoiTx1-containinTAAAAATATTGCG-30 and the reverse primer was 5 0-AATTAA-
AAGCAATTTATTGTATTC-3 0. Genomic DNA was ampliﬁed using
Phusion DNA polymerase (Finnzymes). PCR products were phos-
phorylated, ligated into pBluescript KS+ and sequenced.3. Results
3.1. Toxin puriﬁcation
Crude venom (9 mg) was separated using reverse-phase
chromatography into approximately 25 fractions (Fig. 1A).
The fraction eluted at 20.5 ml, accounting for 11% of the total
absorbance at 220 nm, was the most active against Shaker
channels and further puriﬁed. The active fractions from four
reverse-phase separations were pooled and further puriﬁed
using a Resource S column (Fig. 1B), yielding two main pep-
tides. The fraction eluted at 13.9 ml was further puriﬁed on a
Vydac analytical C18 column (Fig. 1C). Approximately,
27 lg of pure toxin, termed BoiTx1, was eluted at 24.6 ml.
3.2. Characterization and structural analysis of BoiTx1
Out of 300 analyzed cDNA clones, 150 were predicted to en-
code for toxin-like peptides (not shown). The expected molec-
ular weights of the predicted toxins were calculated to create a
database of expected masses. To determine the amino acid se-
quence of BoiTx1, the molecular mass of the toxin was deﬁned
by MALDI-TOF and found to be 4015.6 Da (Fig. 2A). In
addition, the same analysis was applied to the toxin after
reduction and digestion with chymotrypsin (Fig. 2A). The31 35 40 45
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Fig. 2. Identiﬁcation and genomic organization of BoiTx1. (A) Determination of the BoiTx1 sequence using MALDI-TOF analysis of the non-
reduced toxin and its overlapping chymotrypsin-digested fragments. Masses given are those of the native mature peptide with its three disulﬁde
bridges (6 Da) and of the alkylated digested peptides (+171 Da per cysteine residue). Peptide monoisotopic masses are indicated. The results of
Edman N-terminal sequence analysis are indicated at the bottom of the panel. (B) Nucleotide and deduced amino acid sequences of a BoiTx1
genomic clone. Nucleotides are numbered according to the ﬁrst nucleotide coding the peptide. Intron sequences are highlighted in gray and putative
branch points, 5 0-TAAT-30 [18,36], are underlined. The deduced amino acid sequence is given below the nucleotide sequence. The signal peptide is
underlined. The mature toxin sequence is given in bold letters. The putative polyadenylation signal is marked in italics. (C) DNA sequence alignment
of the BoiTx1 genomic gene to BoiTx1 and BmKTx cDNAs. A putative initiator sequence in underlined. Numbers correspond to the full-length
cDNAs. Intron sequences are highlighted in gray. (D) Proposed structure of an a-KTx3 toxin gene. TATA box and initiator sites are shown in gray.
Transcription start sites (TSS) are indicated by arrows.
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masses, yielding only one match. In addition, the sequences of
the ﬁrst ﬁve amino acids of BoiTx1 were determined by Edman
degradation (Fig. 2A). We thus conclude the amino acid se-
quence of BoiTx1 to be GVPINVKCRGSRDCLDPCK-
KAGMRFGKCINSKCHCTP.
3.3. Gene structure
The genomic organization of the BoiTx1 gene was found to
be atypical of scorpion toxins genes. We identiﬁed two introns
within the BoiTx1 gene (Fig. 2B). The ﬁrst, 71 nucleotideslong, is located within the 5 0-untranslated region. The second,
88 nucleotide-long phase I intron, is located within the se-
quence coding for the leader sequence, typical of scorpion tox-
in genes [18]. The junctions of both introns are similar to those
observed in various scorpion toxin genes, i.e., 5 0-GTAAG/C
and AG-3 0 [18]. When aligning the sequence of cDNA clones
of BoiTx1 and BmKTx (a member of the a-KTx3 family),
no homology was detected in the ﬁrst 33 nucleotides. Interest-
ingly, this region showed 73.5% identity to the 3 0 end of the
ﬁrst BoiTx1 intron (Fig. 2C), comparable to the overall
78.2% identity of the two cDNAs. In addition, a possible ini-
A. Kozminsky-Atias et al. / FEBS Letters 581 (2007) 2478–2484 2481tiator element, similar to the initiator consensus sequence
found in Mesotoxin [19,20], was detected within the ﬁrst intron
sequence. These ﬁndings enable us to oﬀer a model for the gene
organization and transcription of a-KTx3 toxins (Fig. 2D). We
propose that all a-KTx3 genes contain two introns, like
BoiTx1. In some genes, like that coding BoiTx1, transcription
is initiated from a putative TATA box located upstream of the
ﬁrst intron. In other genes, like that coding BmKTx, transcrip-
tion is initiated from an initiator located within the ﬁrst intron.
This possible alternative transcription mechanism would yield
5 0-UTRs that vary in length, sequence and possibly mRNA
stability. As two introns were also detected in other scorpion
toxin genes [19,21,22], the proposed gene structure may not
be unique to a-KTx3 toxins. It remains unclear whether the
same gene can employ both transcription mechanisms.10 ms
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currents were considerably reduced.3.4. Comparative sequence analysis
The cDNA product is translated into a 59 amino acid-long
peptide, comprising a 22 amino acid-long leader peptide and
a 37 amino acid-long mature toxin (Fig. 2B). The amino acid
sequence of BoiTx1 was aligned using BLAST [23] and shared
considerable identity of 63–84% with the members of the kalio-
toxin family (a-KTx3; Fig. 5). We thus classiﬁed BoiTx1 as an
a-KTx3.10 [5]. Members of this toxin family are known as
blockers of voltage-gated potassium channels of the Kv1.X
family [12,14]. Some kaliotoxins were also shown to block cal-
cium-activated potassium channels (KCa) [13].
3.5. Electrophysiological studies
The biological eﬀects of BoiTx1 were investigated in X. laevis
oocytes heterologously expressing various potassium channels.4
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Fig. 4. Concentration-dependence of BoiTx1 activity towards Shaker
channels. An IC50 value of 3.5 ± 0.5 nM was measured. Each point
shown is the means ± S.E.M. from ﬁve experiments.
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2482 A. Kozminsky-Atias et al. / FEBS Letters 581 (2007) 2478–2484BoiTx1 (55 nM) reduced K+ currents through Drosophila Sha-
ker channels by 83 ± 2%, yet only had a minor eﬀect on the
structurally-related mammalian channels, rat Kv1.1 and hu-
man Kv1.3 (Fig. 3). Representatives of other mammalian
potassium channels families (rat Kv2.1, rat RomK1 and hu-
man Kv3.4, Kv4.2, KvLQT1, KCNQ2 + 3 and ERG) were
even less aﬀected at the same BoiTx1 concentration (Fig. 3).
Finally, while the IC50 value for Shaker channels was
3.5 ± 0.5 nM (Fig. 4), application of 550 nM BoiTx1 to either
Kv1.1 or Kv1.3 resulted in less than 50% current reduction.R24
K27
Fig. 6. Structural comparison of Osk1 and BoiTx1. A homology
model of BoiTx1 is compared to the three-dimensional structure of
Osk1 (PDB ID: 1SCO) [37]. The three critical residues for toxin-
mediated Kv1.X potassium channel family blockade, Arg24, Lys27
and Asn30 [24], are highlighted in orange. The model structure was
generated with SWISS-MODEL Protein Modeling Server (http://
swissmodel.expasy.org) [41], based on the 3D structures of Osk1,
AgTx2 and KTx1 (PDB ID: 1SCO, 1AGT and 2KTX, respectively).4. Discussion
In this study, we isolated, for the ﬁrst time, a toxin from the
venom of the Israeli scorpion B. occitanus israelis, termed
BoiTx1, and found to be homologus to members of the
a-KTx3 toxin family. As expected, and like its homologs,
BoiTx1 was active against members of the Kv1.X potassium
channel family (i.e. Shaker, Kv1.1 and Kv1.3). However, un-
like other members of its family, BoiTx1 was at least 100-times
more active against the ﬂy Shaker channel than versus its
mammalian counterparts. Accordingly, when injected intoName -KTxα S
BoiTx1 3.10 MKVFFAVLIALFVCSMVIGIHGGVPINV
AgTX1 3.4                               
OsK1 3.7                           I   
Bs6 3.8                               
KTX1 3.1                           E   
AgTX2 3.2                               
AgTX3 3.3                               
BmKTX 3.6 T  I   I     - G   
KTX2 3.5 S    I      I   NA- R P 
KTX3 3.9                         - G P 
Fig. 5. Amino acid sequence comparison of BoiTx1 with other toxins from t
AgTx1-3 from the venom of Leiurus quinquestriatus hebraeus [12], Osk1 from
Buthus sindicus [38], BmKTx from the venom of Buthus martensi [39], KTx1
from the venom of Androctonus australis [13] and KTx3 from the venom of B
found in BoiTx1 at the same position are presented. Hyphens represent absen
degree of identity a toxin shares with BoiTx1. Note that only the leader pepDrosophila larvae, BoiTx1 induced sudden and sustained con-
traction (not shown).
Towards elucidating the molecular basis of its action, a 3D
model of BoiTx1 was generated (Fig. 6), according to the
solved structures of other family members. The three critical
residues for toxin-mediated Kv1.X potassium channel family
blockade, Arg24, Lys27 and Asn30 [24], are present in BoiTx1
and located at similar positions as in related toxins. In addi-
tion, ﬁve of the six important residues for binding of Agitoxin2
to Shaker channels are present in BoiTx1 (i.e. Gly10, Ser11,
Phe25, Thr36 and Pro37) [24]. The unique selectivity of BoiTx1
towards Shaker channels might be explained by structural dif-
ferences that the toxin presents as compared to other members
of its family. Firstly, BoiTx1 is one amino acid shorter than re-
lated toxins, lacking the C-terminal lysine residue normally
found in most other toxin family members. This residue is pre-
dicted to be proximal to Shaker Glu422 [25]. Interestingly, this
position is occupied by proline and alanine in the mammalian
homologs Kv1.3 and Kv1.1 channels, respectively. In addition,
the absence of the C-terminal Lys in BoiTx1 might aﬀect the
spatial position of the adjacent critical residue, Lys24. Sec-
ondly, Met29 was shown to participate in Agitoxin2 bindingequence %I
KCRGSRDCLDPCKKAGMRFGKCINSKCHCTP- 
  T  PQ  K   D          G      K  84 
  KI  Q  E            M G      K  82 
     PQ IQ  RD        M G      Q  79 
  S  PQ  K   D        M R      K  79 
S T  PQ IK   D        M R      K  76 
P T  PQ IK   D        M R      K  76 
  KH GQ  K   D          G  D   K  74 
S KH GQ  K   D        M G  D   K  66 
S KH GQ IK   D        M R  D   K  63 
he a-KTx3 family. The sequence of BoiTx1 was compared with that of
the venom of Orthochirus scrobiculosus [37], Bs6 from the venom of
from the venom of Androctonus mauretanicus mauretanicus [40], KTx2
uthus occitanus tunetanus [15]. Only amino acids that diﬀer from those
t amino acids. Leader peptide amino acids are shown in italics. %I is the
tide amino acid sequences of a-KTx3.5, 3.6 and 3.9 are known.
A. Kozminsky-Atias et al. / FEBS Letters 581 (2007) 2478–2484 2483to Shaker channels [24]. By contrast, Ile29 is found in BoiTx1
and Agitoxin1, both of which display reduced activity towards
Kv1.3 channels, as compared to Agitoxin2, but high potency
towards Shaker channels [12]. Finally, we cannot rule out
the possibility that the unique selectivity of BoiTx1 is due to
the presence of residues adjacent to the binding site that selec-
tively destabilize binding to Kv1.3 channels.
Potent peptide toxins and their derivatives constitute good
lead compounds for the development of novel insecticides
[26–28]. Scorpion toxins cannot penetrate through insect gut
in their native state. Accordingly, various solutions have been
oﬀered to increase their permeability into the circulatory sys-
tem of target animals, including fusion to the snowdrop lectin
(Galanthus nivalis agglutinin) [29], expression in plant cells in
parallel to chitinase for digestion of the insect gut membrane
[30], or the use of insect-selective baculoviruses engineered
with genes encoding insect-selective toxins [31–35]. To date,
such approaches have only been employed with scorpion tox-
ins aﬀecting insect sodium channels. Here, we suggest a new
target for insect-selective insecticides, i.e., the potassium volt-
age-gated channel. The enhancement of the neuronal sodium
current mediated by scorpion venom is accompanied by a
blockage of the potassium voltage-gated current, so as to max-
imize the toxic eﬀect. The concurrent use of an anti-insect-spe-
ciﬁc potassium channel blocker would thus be expected to
augment the insecticidal eﬀects of currently-used sodium chan-
nel modiﬁers. Therefore, we propose BoiTx1 as a lead com-
pound for engineering a novel class of potential insecticides.
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